HCPCS Level II · Drugs administered other than oral method
J8515Cabergoline, oral, 0.25 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J8515
J8515 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing cabergoline, oral, 0.25 mg.
It was added to HCPCS effective 01/01/2006.
Its Medicare coverage code is "M", meaning it is not covered by Medicare.
Details
- Short description
- Cabergoline, oral 0.25mg
- Date added
- 01/01/2006
- Action effective
- 01/01/2006
- BETOS
- O1E
Related J85xx codes
- J8501Aprepitant, oral, 5 mg
- J8502Injection, aprepitant (aponvie), 1 mg
- J8510Busulfan; oral, 2 mg
- J8522Capecitabine, oral, 50 mg
- J8530Cyclophosphamide; oral, 25 mg
- J8540Dexamethasone, oral, 0.25 mg
- J8541Dexamethasone (hemady), oral, 0.25 mg
- J8560Etoposide; oral, 50 mg
- J8565Gefitinib, oral, 250 mg
- J8597Antiemetic drug, oral, not otherwise specified
Common questions about J8515
Is HCPCS J8515 still valid?
- Yes. J8515 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J8515?
- Its coverage code is "M": it is not covered by Medicare. Check the local coverage determination for your region.